Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC)

Títulos similares

• Co-delivery of Gefitinib and Paclitaxel as Inhalable Nano Carriers for Non Small Cell Lung Cancer
  por: Walvekar Shreya
• Cisplatin- Loaded Oxidized Graphene Nanoribbons for Non-Small Cell Lung Carcinoma (NSCLC)
  por: Steffi Augustine
• Targeted Delivery of Nisin and Nisin-Chitosan Complex Using Dendrimers in Lung Cancer
  por: Mayekar Srushti
• Drug Latentiation of a Gefitinib, An Epidermal Growth Factor Receptor (EGFR) Inhibitor, Anticancer (Pro-Drug of Gefitinib) with Cell Line Studies
  por: Mrunal Sharma
  Publicado: (2017)
• Hyaluronic acid modified Erlotinib-Chitosan nanoparticles for Non-small cell lung cancer
  por: Chaitali Taiwade